Neutralizing antibodies after three doses of the BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron-predominant wave

Neutralizing antibodies after three doses of the BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron-predominant wave

Objectives: To investigate the role of immunogenicity after the third vaccine dose against Omicron infection and COVID-19-compatible symptoms of infection. Methods: First, we examined vaccine effectiveness (VE) of the third dose against the second dose during the Omicron wave among the staff at a te...

Full description

Bibliographic Details
Main Authors: Shohei Yamamoto, Kouki Matsuda, Kenji Maeda, Kumi Horii, Kaori Okudera, Yusuke Oshiro, Natsumi Inamura, Junko S. Takeuchi, Maki Konishi, Mitsuru Ozeki, Tetsuya Mizoue, Haruhito Sugiyama, Nobuyoshi Aoyanagi, Hiroaki Mitsuya, Wataru Sugiura, Norio Ohmagari
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:International Journal of Infectious Diseases
Subjects:
Omicron
Third dose
COVID-19
Breakthrough infection
Neutralizing antibody
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971223000231

Internet

http://www.sciencedirect.com/science/article/pii/S1201971223000231

Similar Items